Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-30 4:12 pm Purchase | 2022-12-22 | 13G | Iovance Biotherapeutics, Inc. IOVA | MHR FUND MANAGEMENT LLC | 12,083,951 6.700% | 12,083,951 (New Position) | Filing History |
| 2022-02-24 5:23 pm Sale | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | BlackRock Inc. BLK | 7,408,505 4.700% | -1,594,083 (-17.71%) | Filing History |
| 2022-02-14 3:48 pm Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 10,127,941 6.500% | 961,637 (+10.49%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | T. Rowe Price Associates, Inc. | 4,663,785 2.900% | -2,718,420 (-36.82%) | Filing History |
| 2022-02-11 10:04 am Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | AVORO CAPITAL ADVISORS LLC | 8,675,000 5.500% | 1,175,000 (+15.67%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | The Vanguard Group | 12,197,787 7.770% | 332,405 (+2.80%) | Filing History |
| 2022-02-04 2:25 pm Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | FRANKLIN RESOURCES INC BEN | 5,797,716 3.700% | 818,250 (+16.43%) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Wellington Management Group LLP | 9,584,082 6.110% | 9,584,082 (New Position) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 9,166,304 6.300% | -245,092 (-2.60%) | Filing History |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | T. Rowe Price Associates, Inc. | 7,382,205 5.000% | 872,349 (+13.40%) | Filing History |
| 2021-02-12 08:03 am Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | AVORO CAPITAL ADVISORS LLC | 7,500,000 5.100% | -1,326,039 (-15.02%) | Filing History |
| 2021-02-10 11:10 am Purchase | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | The Vanguard Group | 11,865,382 8.090% | 1,012,253 (+9.33%) | Filing History |
| 2021-02-01 5:05 pm Purchase | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | FRANKLIN RESOURCES INC BEN | 8,928,904 6.100% | 3,451,148 (+63.00%) | Filing History |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | BlackRock Inc. BLK | 9,002,588 6.100% | -592,072 (-6.17%) | Filing History |
| 2021-01-11 2:21 pm Purchase | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | ARK Investment Management LLC | 15,297,822 10.430% | 15,297,822 (New Position) | Filing History |